The effect of substance P1-7 amide on nociceptive threshold in diabetic mice

Peptides

Volumn 32, Issue 1, 2011, Pages 93-98

  Ohsawa, Masahiro ^a   Carlsson, Anna ^b   Asato, Megumi ^a   Koizumi, Takayuki ^a   Nakanishi, Yuki ^a   Fransson, Rebecca ^b   Sandström, Anja ^b   Hallberg, Mathias ^b   Nyberg, Fred ^b   Kamei, Junzo ^a  

^a HOSHI UNIVERSITY   (Japan)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antinociception; Diabetes; Opioid receptors; Sigma receptor; Substance P fragment substance P1 7; Substance P1 7 amide

Indexed keywords

BETA FUNALTREXAMINE; BINALTORPHIMINE; DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALOXONE; NALTRINDOLE; PENTAZOCINE; SUBSTANCE P [1-7]; ANALGESIC AGENT; PEPTIDE FRAGMENT; SUBSTANCE P; SUBSTANCE P (1 7); SUBSTANCE P (1-7);

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; TAIL FLICK TEST; ANIMAL; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRASPINAL DRUG ADMINISTRATION; METABOLISM; NOCICEPTIVE RECEPTOR; PAIN ASSESSMENT; PAIN THRESHOLD;

MUS;

ANALGESICS; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, SPINAL; MICE; MICE, INBRED ICR; NOCICEPTORS; PAIN MEASUREMENT; PAIN THRESHOLD; PEPTIDE FRAGMENTS; SUBSTANCE P;

EID: 78650522382     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.09.029     Document Type: Article

References (50)

1. M. Benuck, and N. Marks Enzymatic inactivation of substance P by a partially purified enzyme from rat brain Biochem Biophys Res Commun 65 1975 153 160
2. M. Botros, M. Hallberg, T. Johansson, Q. Zhou, G. Lindeberg, and P.A. Frandberg Endomorphin-1 and endomorphin-2 differentially interact with specific binding sites for substance P (SP) aminoterminal SP1-7 in the rat spinal cord Peptides 27 2006 753 759
3. M. Botros, T. Johansson, Q. Zhou, G. Lindeberg, C. Tomboly, and G. Toth Endomorphins interact with the substance P (SP) aminoterminal SP(1-7) binding in the ventral tegmental area of the rat brain Peptides 29 2008 1820 1824
4. A. Carlsson, M. Ohsawa, M. Hallberg, F. Nyberg, and J. Kamei Substance P(1-7) induces antihyperalgesia in diabetic mice through a mechanism involving the naloxone-sensitive sigma receptors Eur J Pharmacol 626 2010 250 255
5. C.M. Cendan, J.M. Pujalte, E. Portillo-Salido, and J.M. Baeyens Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice Psychopharmacology (Berl) 182 2005 485 493
6. C.M. Cendan, J.M. Pujalte, E. Portillo-Salido, L. Montoliu, and J.M. Baeyens Formalin-induced pain is reduced in sigma (1) receptor knockout mice Eur J Pharmacol 511 2005 73 74
7. F.E. D'amour, and D.L. Smith A method for determining loss of pain sensation J Pharm Exp Ther 72 1941 74 79
8. B. de la Puente, X. Nadal, E. Portillo-Salido, R. Sanchez-Arroyos, S. Ovalle, and G. Palacios Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury Pain 145 2009 294 303
9. P.J. Dyck, T.S. Larson, P.C. O'Brien, and J.A. Velosa Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group Diabetes Care 23 2000 510 517
10. E.L. Feldman, J.W. Russell, K.A. Sullivan, and D. Golovoy New insights into the pathogenesis of diabetic neuropathy Curr Opin Neurol 12 1999 553 563
11. R. Fransson, M. Botros, F. Nyberg, G. Lindeberg, A. Sandstrom, and M. Hallberg Small peptides mimicking substance P (1-7) and encompassing a C-terminal amide functionality Neuropeptides 42 2008 31 37
12. G. Gekker, S. Hu, W.S. Sheng, R.B. Rock, J.R. Lokensgard, and P.K. Peterson Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1 Int Immunopharmacol 6 2006 1029 1033
13. M. Hallberg, and F. Nyberg Neuropeptide conversion to bioactive fragments - an important pathway in neuromodulation Curr Protein Pept Sci 4 2003 31 44
14. D.L. Hoffman, A. Sadosky, E.M. Dukes, and J. Alvir How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy? Pain 149 2010 194 201
15. C.S. Hornfeldt, K.F. Kitto, and A.A. Larson Evidence that the NH2-terminus of substance P modulates N-methyl-d-aspartate-induced activity by an action involving sigma receptors Eur J Pharmacol 306 1996 15 22
16. M.R. Hutchinson, Y. Zhang, K. Brown, B.D. Coats, M. Shridhar, and P.W. Sholar Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4) Eur J Neurosci 28 2008 20 29
17. M.R. Hutchinson, Y. Zhang, M. Shridhar, J.H. Evans, M.M. Buchanan, and T.X. Zhao Evidence that opioids may have toll-like receptor 4 and MD-2 effects Brain Behav Immun 24 2010 83 95
18. J.L. Hylden, and G.L. Wilcox Intrathecal morphine in mice: a new technique Eur J Pharmacol 67 1980 313 316
19. J.L. Hylden, and G.L. Wilcox Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice Brain Res 217 1981 212 215
20. O.J. Igwe, D.C. Kim, V.S. Seybold, and A.A. Larson Specific binding of substance P aminoterminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes J Neurosci 10 1990 3653 3663
21. J. Kamei, Y. Iwamoto, M. Misawa, H. Nagase, and Y. Kasuya Antinociceptive effect of l-arginine in diabetic mice Eur J Pharmacol 254 1994 113 117
22. H.W. Kim, Y.B. Kwon, D.H. Roh, S.Y. Yoon, H.J. Han, and K.W. Kim Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice Br J Pharmacol 148 2006 490 498
23. A.A. Larson, and X. Sun Modulation of kainic acid-induced activity in the mouse spinal cord by the amino terminus of substance P: sensitivity to opioid antagonists J Pharmacol Exp Ther 265 1993 159 165
24. K. Mardon, M. Kassiou, and A. Donald Effects of streptozotocin-induced diabetes on neuronal sigma receptors in the rat brain Life Sci 65 1999 PL281 PL286
25. R.R. Matsumoto, W.D. Bowen, and J.M. Walker Down-regulation of sigma receptors by chronic haloperidol Prog Clin Biol Res 328 1990 125 128
26. R.R. Matsumoto, W.D. Bowen, J.M. Walker, S.L. Patrick, A.C. Zambon, and V.N. Vo Dissociation of the motor effects of (+)-pentazocine from binding to sigma 1 sites Eur J Pharmacol 301 1996 31 40
27. D.D. Mousseau, and A.A. Larson Substance P analogs displace sigma binding differentially in the brain and spinal cord of the adult mouse Metab Brain Dis 9 1994 249 255
28. F. Nyberg, and M. Hallberg Peptide conversion - a potential pathway modulating G-protein signaling Curr Drug Targets 8 2007 147 154
29. F. Nyberg, P. Le Greves, C. Sundqvist, and L. Terenius Characterization of substance P(1-7) and (1-8) generating enzyme in human cerebrospinal fluid Biochem Biophys Res Commun 125 1984 244 250
30. M. Ohsawa, and J. Kamei Modification of kappa-opioid receptor agonist-induced antinociception by diabetes in the mouse brain and spinal cord J Pharmacol Sci 98 2005 25 32
31. M. Ohsawa, and J. Kamei Possible involvement of spinal protein kinase C in thermal allodynia and hyperalgesia in diabetic mice Eur J Pharmacol 372 1999 221 228
32. M.S. Ola, P. Moore, D. Maddox, A. El-Sherbeny, W. Huang, and P. Roon Analysis of sigma receptor (sigmaR1) expression in retinal ganglion cells cultured under hyperglycemic conditions and in diabetic mice Brain Res Mol Brain Res 107 2002 97 107
33. B. Pernow, and P. Substance Pharmacol Rev 35 1983 85 141
34. D.H. Roh, S.Y. Yoon, H.S. Seo, S.Y. Kang, J.Y. Moon, and S. Song Sigma-1 receptor-induced increase in murine spinal NR1 phosphorylation is mediated by the PKCalpha and epsilon, but not the PKCzeta, isoforms Neurosci Lett 477 2010 95 99
35. T. Sakurada, P. Le Greves, J. Stewart, and L. Terenius Measurement of substance P metabolites in rat CNS J Neurochem 44 1985 718 722
36. M. Sosnowski Pain management: physiopathology, future research and endpoints Support Care Cancer 1 1993 79 88
37. J.M. Stewart, M.E. Hall, J. Harkins, R.C. Frederickson, L. Terenius, and T. Hokfelt A fragment of substance P with specific central activity: SP(1-7) Peptides 3 1982 851 857
38. R.J. Tallarida, F. Porreca, and A. Cowan Statistical analysis of drug-drug and site-site interactions with isobolograms Life Sci 45 1989 947 961
39. L.I. Tsao, and T.P. Su Naloxone-sensitive, haloperidol-sensitive, [3H](+)SKF-10047-binding protein partially purified from rat liver and rat brain membranes: an opioid/sigma receptor? Synapse 25 1997 117 124
40. M Tsuda, H. Ueno, A. Kataoka, H. Tozaki-Saitoh, and K. Inoue Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling Glia 56 2008 378 386
41. H. Ueda Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms Pharmacol Ther 109 2006 57 77
42. H. Ueda, S. Tamura, M. Satoh, and H. Takagi Excess release of substance P from the spinal cord of mice during morphine withdrawal and involvement of the enhancement of presynaptic Ca2+ entry Brain Res 425 1987 101 105
43. L.R. Watkins, M.R. Hutchinson, K.C. Rice, and S.F. Maier The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia Trends Pharmacol Sci 30 2009 581 591
44. D. Wiktelius, Z. Khalil, and F. Nyberg Modulation of peripheral inflammation by the substance P N-terminal metabolite substance P1-7 Peptides 27 2006 1490 1497
45. R. Wodarski, A.K. Clark, J. Grist, F. Marchand, and M. Malcangio Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats Eur J Pain 13 2009 807 811
46. H.E. Wu, J.S. Hong, and L.F. Tseng Stereoselective action of (+)-morphine over (-)-morphine in attenuating the (-)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse Eur J Pharmacol 571 2007 145 151
47. Q. Zhou, A. Carlsson, M. Botros, R. Fransson, A. Sandstrom, and T. Gordh The C-terminal amidated analogue of the substance P (SP) fragment SP(1-7) attenuates the expression of naloxone-precipitated withdrawal in morphine dependent rats Peptides 30 2009 2418 2422
48. Q. Zhou, P.A. Frandberg, A.M. Kindlundh, P. Le Greves, and F. Nyberg Substance P(1-7) affects the expression of dopamine D2 receptor mRNA in male rat brain during morphine withdrawal Peptides 24 2003 147 153
49. Q. Zhou, Z. Liu, A. Ray, W. Huang, K. Karlsson, and F. Nyberg Alteration in the brain content of substance P (1-7) during withdrawal in morphine-dependent rats Neuropharmacology 37 1998 1545 1552
50. W. Zieglgansberger, A. Berthele, and T.R. Tolle Understanding neuropathic pain CNS Spectr 10 2005 298 308